Skip to main content
. 2020 Jun 10;18(2):1803. doi: 10.18549/PharmPract.2020.2.1803

Table 1. Guidelines with the recommendations for dual antiplatelet therapy.

Indication for DAPT Recommended duration of DAPT Guideline (reference #)
Minor non-cardioembolic ischemic stroke (NIHSS score≤3) who did not receive IV alteplase ASA + clopidogrel; 21 days 2,3
Acute coronary syndrome DAPT; 3-36 months, in general 12 months 4
PCI in stable CAD setting DAPT; 1-12 months 4
TAVI without high bleeding risk ASA + clopidogrel; 3-6 months 5
Below the knee bypass with a prosthetic graft ASA + clopidogrel; at least 1 year 6,7
Carotid artery stenting ASA + clopidogrel; at least 1 month 8
Revascularization percutaneous in patients with lower extremity artery disease or infra-inguinal stent implementation ASA + clopidogrel; at least 1 month 6,7,9

DAPT: dual antiplatelet therapy; NIHSS: National Institutes of Health Stroke Scale; PCI: Percutaneous Coronary Intervention; CAD: Coronary artery disease; TAVI: Transcatheter aortic valve implantation; ASA: acetylsalicylic acid